20519 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
METHODS OF TREATMENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#602Methods of treating obstructive lung diseases using bitter tastants
#603TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES
#604Methods And Compositions For Administering A Specific Wavelength Phototherapy
#605COMPOSITION POSSESSING ANTIOXIDANT, IMMONOMODULATED, AND ANTITUMOROUS ACTION AND METHOD OF TREATING NEOPLASMS
#606COMPOSITION AND METHOD OF DELIVERY OF L-ARABINOSE AND SELECT COMPOUNDS
#607COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM
#608PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR
#609High-purity steviol glycosides
#610Phenolic compositions derived from apple skin and uses thereof
#611Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#612Compositions and Methods for Treating Pain
#613TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND
#614Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#615USE OF AN ACTIVE INGREDIENT COMBINATION THAT CONTAINS HYDROXYSTILBENE FOR PREVENTING AND/OR TREATING DISEASES
#616PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#617Formulations from derivatives of curcumin, paclitaxel, and aspirin
#618Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#619Compounds and compositions for treating infection
#6207-hydroxy chromones as potent antioxidants
#621Doxorubicin adjuvants to reduce toxicity and methods for using the same
#622Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#623Compounds and methods for treating bacterial infections
#624COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY
#625Bilayer tablet formulations
#626NYASOL AND ANALOGS THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR BETA-MEDIATED DISEASES
#627FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE
#628FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE
#629USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASE
#630Pharmaceutical formulations containing an SGLT2 inhibitor
#631Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
#632Antibiotic formulations, unit doses, kits, and methods
#633Methods for preventing or treating sarcopenia and muscle atrophy in animals
#634Arabinoxylans for modulating the barrier function of the intestinal surface
#635Antibiotic formulations, unit doses, kits, and methods
#636METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES
#637Glycoside derivative and uses thereof
#638PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#639Ophthalmic formulations and uses thereof
#640DOSAGE FORMS OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR TREATING MENOPAUSAL COMPLAINTS
#641Topical Delivery with a Carrier Fluid
#642Compositions and methods for increasing lifespan and health span
#643COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#644Stilbenoid derivatives and their uses
#645Method for improving blood flow using stilbenoid derivatives
#646NOVEL METHODS FOR MODULATING MELANIN PRODUCTION
#647Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
#648Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate
#649COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION
#650Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
#651Compositions and methods for the prevention and treatment of red blood cell coagulation
#652Combined and extracts for the therapeutic treatment of heart failure
#653COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART DISEASES
#654Methods for treating obesity employing an SGLT2 inhibitor
#655Compositions and methods for the prevention and treatment of brain diseases and conditions
#656Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
#657SGLT2 INHIBITOR DOSAGE FORMS
#658PHARMACEUTICAL COMPOSITIONS
#659METHODS FOR SUPPRESSING AN IMMUNE RESPONSE OR TREATING A PROLIFERATIVE DISORDER
#660Foamable suspension gel
#661Compositions for proliferation of cells and related methods
#662USE OF JASMONATES FOR TREATING HEART FAILURE AND RELATED CARDIAC DISORDERS
#663Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG)
#664COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONS
#665Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
#666Adenosine analogs and their use
#667Drug Delivery Composition Comprising a Self-Assembled Gelator
#668THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION
#669Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
#670Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate
#671Anionic conjugates of glycosylated bacterial metabolite
#672Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections
#673Crystal structures of SGLT2 inhibitors and processes for preparing same
#674High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof
#675USE OF VITAMIN D GLYCOSIDES AND SULFATES FOR TREATMENT OF DISEASE
#676Acteoside and acteoside-rich plant extracts for increasing athletic performance in humans
#677Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
#678Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#679PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR
#680COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#681Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses
#682Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same
#683Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
#684Pharmaceutical formulations containing an SGLT2 inhibitor
#685Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
#686USE OF FLAVONOIDE COMPOUNDS FOR THE PROPHYLAXIS AND THERAPY OF ISCHAEMIC OR INFLAMMATORY HEART AND CARDIOVASCULAR DISEASES
#687Methods and compositions related to viral inhibition
#688PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#689Selective Targeting Agents for Mitochondria
#690Herbal enhanced analgesic formulations
#691Acne treatment composition and methods for using
#692COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
#693Compositions And Methods For The Treatment Of Muscular Dystrophy
#694Antibiotic formulations, unit doses, kits and methods
#695Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
#696Stabilization of oily suspensions comprising hydrophobic silicas
#697Method for glycosylation of flavonoid compounds
#698MATERIALS AND METHODS FOR TREATING DISEASES CAUSED BY GENETIC DISORDERS USING AMINOGLYCOSIDES AND DERIVATIVES THEREOF WHICH EXHIBIT LOW NEPHROTOXICITY
#699Polyacetylenic compounds for stimulating insulin gene exression, production and secretion
#700Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient
#701METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES
#7027-hydroxy chromones as potent antioxidants
#703COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS
#704Use of α-glucosidase inhibitors to treat alphavirus infections
#705Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#706Anti-cholesterolemic compounds and methods of use
#707Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#708Method of treating intrauterine inflammation
#709EPITOPE REDUCTION THERAPY
#710Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use
#711COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#712Alpha-galactosyl ceramide analogs and their use as immunotherapies
#713Doxorubicin adjuvants to reduce toxicity and methods for using the same
#714Chinese herb extract for treating dementia and preparation method thereof
#715Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases
#716Antibiotic Formulations, Unit Doses, Kits, and Methods
#717Pan-selectin inhibitor with enhanced pharmacokinetic activity
#718Novel Combinations of DNAK Inhibitors With Known Antibacterial Agents
#719NARACTIN COMPOSITIONS FOR THE INHIBITION OF REACTIVE OXYGEN SPECIES
#720PHARMACEUTICAL FORMULATIONS
#721Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#722Use of Active Ingredients Containing Hydroxystilbene for Preventing and/or Treating Osteoporosis
#723WHITENING COSMETIC COMPOSITION CONTAINING ARBUTIN NANOPARTICLES
#724Method for producing a drug extract that contains hydroxystilbene
#725Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
#726Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
#727Sulfotransferase inhibitors
#728Drug for Ameliorating Male Climacteric Disorders
#729Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
#730Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field
#731Pharmaceutical composition containing polydatin and its application
#732Composition for Prevention or Alleviation of Pigmentation
#733Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
#734COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#735Methods for treating obesity employing an SGLT2 inhibitor
#736Pharmaceutical formulations containing an SGLT2 inhibitor
#737Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection
#738Polyacetylenic compounds
#739Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate
#740HYBRID LIPID-POLYMER NANOPARTICULATE DELIVERY COMPOSITION
#741Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
#742Self-Preserved Ophthalmic Pharmaceutical Compositions Containing Tobramycin
#743Anti-cancer combinations
#744Anti-cancer combinations
#745Anti-cancer combinations
#746Anti-cancer combinations
#747Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
#748Crystal structures of SGLT2 inhibitors and processes for preparing same
#749NASAL FORMULATION
#750Topical anesthetic formulation
#751DEVICES, METHODS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS, RHINITIS, AND OTHER DISORDERS
#752Stable emulsion formulations
#753TOPICAL PREPARATION DISPENSERS AND METHODS OF USING THE SAME
#754Multifunctional supramolecular hydrogels as biomaterials
#755Foamable suspension gel
#756Antimicrobial composition
#757Topical cosmetic compositions containing alpha arbutin
#758Pharmaceutical Formulations
#759Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#760Phenol derivative, medicinal composition containing the same, and medicinal use thereof
#761Guanidinium derivatives for improved cellular transport
#762Methods for suppressing an immune response or treating a proliferative disorder
#763Method and composition for treating otitis media
#764Compositions capable of facilitation penetration across a biological barrier
#765SELECTIVE TARGETING AGENTS FOR MITCOCHONDRIA
#766Fluid composition used to stimulate human synovial fluid
#767DRUG DELIVERY SYSTEM
#768Method of treating and/or preventing cancers using Sartans and/or Statins to modulate VDR, and/or PPAR, and/or GCR and/or CB1 receptors; in conjunction with certain bacteriostatic antibiotics
#769Uses of rifamycins
#770Processes for Obtaining Lignan Extracts and Compositions Containing the Lignan Extracts
#771Injectable compositions for the controlled delivery of pharmacologically active compound
#772Wound healing compound
#773Antibiotic formulations, unit doses, kits, and methods
#774Vancomycin formulations having reduced amount of histamine
#775Vancomycin formulations having reduced amount of histamine
#776Vancomycin formulations having reduced amount of histamine
#777Cosmetic composition comprising at least one anti-dandruff agent and also oxyethylenated sorbitan monolaurate, and cosmetic treatment process using said composition
#778Combination of acetylsalicylic acid and alpha-glucosidase inhibitors
#779Organic nanoparticles and associated methods
#780Topical pharmaceutical composition for the treatment of inflammatory dermatoses
#781Aminoglycoside antibiotics for use as vap-1/ssao inhibitors
#782Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
#783Methods and compositions for the prevention of toxic side effects of aminoglycoside medications
#784High delivery rates for lipid based drug formulations, and methods of treatment thereof
#785Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
#786Anti-cancer combinations
#787Compositions and methods using proton pump inhibitors
#788Method for treating otitis externa
#789Resonance modulator for diagnosis and therapy
#790Stimulation of cellular regeneration and differentiation in the inner ear
#791Compounds useful in coating stents to prevent and treat stenosis and restenosis
#792Topical Delivery with a Carrier Fluid
#793Methods for treating diabetes and related disorders using pde10a inhibitors
#794Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
#795Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments
#796Pharmaceutical compositions to treat diseases caused by mycobacterium
#797Combinations of DnaK inhibitors with known antibacterial agents
#798PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
#799Compositions and methods for the treatment of muscular dystrophy
#800Methods and pharmaceutical compositions for treating sepsis
#801Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
#802Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of visual disabilities
#803Use of alpha-glucosidase inhibitors to treat alphavirus infections
#804New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations
#805Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
#806Methods and composition for the treatment of cystic fibrosis and related illnesses
#807Pharmaceutical compositions for alleviating excess levels of sugar in diabetic patients
#808Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
#809Attenuation of disorders by aminoglycosides
#810Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use
#811Anti bacterial compounds
#812Control of biofilm with a biofilm inhibitor
#813Classes of compounds that interact with GPCRs
#814Acne gel
#815Combination therapy for controlled carbohydrate digestion
#816Topical cosmetic compositions comprising alpha arbutin
#817METHODS OF TREATING EPITHELIAL LESIONS
#818Ophthalmic formulations and uses thereof
#819Methods for combating ischemic injury to epithelial organ
#820Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations
#821Self-preserved ophthalmic pharmaceutical compositions containing tobramycin
#822Composition for topical treatment of mixed vaginal infections
#823Compositions and methods of treating irritation and kit therefor
#824Sulfotransferase inhibitors
#825Breast cancer resistance protein () inhibitor
#826Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions
#827Novel factor viia inhibiting compounds
#828Novel compounds that inhibit factor xa activity
#829Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same
#830Process for producing glycoside
#831Detection of CDX2 expression
#8327-hydroxy chromones as potent antioxidants
#833Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#834Injectable compositions for the controlled delivery of pharmacologically active compound
#835Crystals of glucopyranosyloxybenzyl benzene derivative
#836Injectable compositions for the controlled delivery of pharmacologically active compound
#837Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
#838Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#839Compounds that inhibit factor xa activity
#840Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases
#841Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2-0-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-(2-0-acetyl-alpha-L-arabinopyranoside)] or OSW-1 and its derivatives for cancer therapeutics
#842Application of phenyl glucuronide in preparing drug for pre-warning of cancer via induced volatolomics
#843Method of treating trypanosomiasis
#844Formulation for alleviating veisalgia symptoms
#845Anti-blepharitis compositions and their use